North China Pharmaceutical Company.Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. Th...
NCPC: In the third quarter, the net profit attributable to the parent company was 35.0066 million yuan, an increase of 14.85% year-on-year
NCPC: Wholly-owned subsidiary receives approval notice for the listing application of Cefoperazone chemical raw materials
NCPC: Southern Company Obtains Drug Registration Certificate
NCPC has obtained the drug registration certificate for injectable vancomycin hydrochloride (0.5g)
NCPC released its semi-annual performance report, with a net profit attributable to the parent company of 123 million yuan, a year-on-year increase of 71.56%
NCPC: Adenosylcobalamin Capsules (0.5mg) have obtained the drug registration certificate